|
Mechanism50S subunit inhibitors [+3] |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Active, not recruitingPhase 3 评估他扎克林乳膏治疗中度寻常性痤疮的安全性和有效性的多中心、随机、单盲、阳性药平行对照的Ⅲ期临床试验
[Translation] A multicenter, randomized, single-blind, active-controlled phase III clinical trial to evaluate the safety and efficacy of tazaclalin cream in the treatment of moderate acne vulgaris
本试验为Ⅲ期临床试验,旨在探索他扎克林乳膏对比他扎罗汀乳膏、克林霉素磷酸酯凝胶单独用药治疗中度寻常性痤疮的有效性和安全性。
[Translation] This is a phase III clinical trial designed to explore the efficacy and safety of tazarotene cream compared with tazarotene cream or clindamycin phosphate gel alone in the treatment of moderate acne vulgaris.
100 Clinical Results associated with Institute of Dermatology, Chinese Academy of Medical Sciences
0 Patents (Medical) associated with Institute of Dermatology, Chinese Academy of Medical Sciences
100 Deals associated with Institute of Dermatology, Chinese Academy of Medical Sciences
100 Translational Medicine associated with Institute of Dermatology, Chinese Academy of Medical Sciences